A trial of rocapuldencel-T for kidney cancer that has spread (ADAPT)

Overview

Cancer types:

Kidney cancer, Renal cell cancer

Status:

Results

Phase:

Phase 3

Details

This trial looked at a drug called rocapuldencel-T for kidney cancer that has spread.

People could join the trial between 2012 and 2016. The research team published the results in 2020.

There is a link to more information in the ‘Summary of results’ section below.

Recruitment start: 1 November 2012

Recruitment end: 31 May 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Tim Eisen

Supported by

Argos Therapeutics

NIHR Clinical Research Network: Cancer

Last reviewed: 06 Oct 2026

CRUK internal database number: 11894

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Connect with other people affected by cancer and share your experiences.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.